To amend title XVIII of the Social Security Act to promote laboratory price transparency under the Medicare program.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend title XVIII of the Social Security Act to promote laboratory price transparency under the Medicare program., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Environment.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H21D4773AC1304DC4A772CBBF16759F90: 1. Short title This Act may be cited as the Clinical Laboratory Price Transparency Act of 2023.
- Section H7FADF48E2ED14E5C9FC59DFDD478750C: 2. Promoting laboratory price transparency under the Medicare program Part E of title XVIII of the Social Security Act (42 U.S.C. 1395x et seq.) is amended by...
- Section H34507BA2299A4FA5857C44B5AD15322A: 1899C. Laboratory price transparency requirement Beginning January 1, 2025, each applicable laboratory that receives payment under this title for furnishing a...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend title XVIII of the Social Security Act to promote laboratory price transparency under the Medicare program., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Environment
Primary Purpose
This bill, To amend title XVIII of the Social Security Act to promote laboratory price transparency under the Medicare program., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Legislative Progress
IntroducedMrs. Miller of West Virginia introduced the following bill; which …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology